Clement PMJ, Dirven L, Eoli M, Sepulveda-Sanchez JM, et al. Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma. Eur J Cancer 2021;147:1-12.
PMID: 33601293